Concurrent Investment Advisors’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$528K Buy
4,818
+1,336
+38% +$190K 0.01% 1190
2025
Q4
$579K Sell
3,482
-756
-18% -$126K 0.01% 1081
2025
Q3
$830K Buy
4,238
+667
+19% +$110K 0.01% 711
2025
Q2
$323K Buy
+3,571
New +$282K 0.01% 1031

Other funds holding ALAB

Concurrent Investment Advisors's ALAB Position: Q1 2026 in Review

Concurrent Investment Advisors increased its Astera Labs (ALAB) stake by 38% in Q1 2026, buying an estimated $190K and bringing the position to 4,818 shares worth $528K. The position accounts for 0.01% of the portfolio, ranked #1190.

Concurrent Investment Advisors first reported a position in ALAB in Q2 2025 and has held it in 4 quarters since. The position peaked at $830K in Q3 2025. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • Concurrent Investment Advisors held 4,818 shares of Astera Labs worth $528K as of Q1 2026.
  • Concurrent Investment Advisors bought 1,336 Astera Labs shares in Q1 2026, an estimated $190K.
  • Astera Labs made up 0.01% of Concurrent Investment Advisors's portfolio in Q1 2026, its #1190 holding.
  • Concurrent Investment Advisors first reported a position in Astera Labs in Q2 2025 and has held it in 4 quarters since.
  • Concurrent Investment Advisors's Astera Labs position peaked at $830K in Q3 2025.
  • 703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on Concurrent Investment Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.